Hypromellose 0.2 % / naphazoline HCl 0.025 % / polysorbate 80 0.5 % / zinc sulfate 0.25 % Ophthalmic Gel
RxNorm 1374718

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1374718 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: hypromellose 0.2 % / naphazoline HCl 0.025 % / polysorbate 80 0.5 % / zinc sulfate 0.25 % Ophthalmic Gel.

The following semantic concepts and normalized strings are associated with this clinical entity:

SCD
Hypromellose 0.002 mg/MG / naphazoline hydrochloride 0.00025 mg/MG / polysorbate 80 0.005 mg/MG / zinc sulfate 0.0025 mg/MG Ophthalmic Gel
Primary clinical definition
AUI:12346450
View
SY
Hypromellose 0.002 mg/MG / Naphazoline Hydrochloride 0.00025 mg/MG / Polysorbate 80 0.005 mg/MG / ZnSO4 0.0025 mg/MG Ophthalmic Gel
AUI:5085272
View
PSN
Hypromellose 0.2 % / naphazoline HCl 0.025 % / polysorbate 80 0.5 % / zinc sulfate 0.25 % Ophthalmic Gel
AUI:6388022
View
SY
Hypromellose 0.2 % / naphazoline hydrochloride 0.025 % / polysorbate 80 0.5 % / zinc sulfate 0.25 % Ophthalmic Gel
AUI:5084384
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SCDPrescribable

Semantic Clinical Drug (SCD):
Hypromellose 0.002 mg/MG / naphazoline hydrochloride 0.00025 mg/MG / polysorbate 80 0.005 mg/MG / zinc sulfate 0.0025 mg/MG Ophthalmic Gel
(Atom ID: 12346450)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
hypromellose 0.002 MG/MG / naphazoline hydrochloride 0.00025 MG/MG / polysorbate 80 0.005 MG/MG / zinc sulfate 0.0025 MG/MG Ophthalmic Gel
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1374718
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12346450
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCD
Semantic Clinical Drug (Ingredient + Strength + Dose Form)
Source Code
1374718
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{1374713} 27334
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1374714} 82054
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1374715} 8560
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1374716} 39954
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{1374713} 27334
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1374714} 7247
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1374715} 8560
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1374716} 11416
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AVAILABLE STRENGTH
0.002 MG/MG / 0.00025 MG/MG / 0.005 MG/MG / 0.0025 MG/MG
Available drug strengths listed in the order of ingredients from the drug
RXN BOSS FROM
{1374713} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1374714} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1374715} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1374716} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN HUMAN DRUG
US
Drug available for use in Humans
RXTERM FORM
Gel
The RxTerm dose form name for this drug
SYPrescribable

Synonym (SY):
Hypromellose 0.002 mg/MG / Naphazoline Hydrochloride 0.00025 mg/MG / Polysorbate 80 0.005 mg/MG / ZnSO4 0.0025 mg/MG Ophthalmic Gel
(Atom ID: 5085272)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
hypromellose 0.002 MG/MG / Naphazoline Hydrochloride 0.00025 MG/MG / Polysorbate 80 0.005 MG/MG / ZnSO4 0.0025 MG/MG Ophthalmic Gel
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1374718
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
5085272
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1374718
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
PSNPrescribable

Prescribable Name (PSN):
Hypromellose 0.2 % / naphazoline HCl 0.025 % / polysorbate 80 0.5 % / zinc sulfate 0.25 % Ophthalmic Gel
(Atom ID: 6388022)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
hypromellose 0.2 % / naphazoline HCl 0.025 % / polysorbate 80 0.5 % / zinc sulfate 0.25 % Ophthalmic Gel
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1374718
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
6388022
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
1374718
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SYPrescribable

Synonym (SY):
Hypromellose 0.2 % / naphazoline hydrochloride 0.025 % / polysorbate 80 0.5 % / zinc sulfate 0.25 % Ophthalmic Gel
(Atom ID: 5084384)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
hypromellose 0.2 % / naphazoline hydrochloride 0.025 % / polysorbate 80 0.5 % / zinc sulfate 0.25 % Ophthalmic Gel
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1374718
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
5084384
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1374718
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

Zinc



[Learn More]


* Please review the disclaimer below.